Guerbet Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Villepinte France (1926)

Organization Overview

First Clinical Trial
2006
NCT00447889
First Marketed Drug
1954
ethiodol
First NDA Approval
1995
ioxilan (oxilan)
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Guerbet | GUERBET